TAFASITAMAB-CXIX

TAFASITAMAB-CXIX was reported 906 times

These side effects are most commonly reported by patients taking TAFASITAMAB-CXIX:

# Side effect Count
0 DISEASE PROGRESSION 239
1 OFF LABEL USE 168
2 LYMPHOMA 165
3 DEATH 66
4 DRUG INEFFECTIVE 47
5 DIFFUSE LARGE B-CELL LYMPHOMA 42
6 NEUTROPENIA 39
7 BLOOD LACTATE DEHYDROGENASE INCREASED 38
8 MALIGNANT NEOPLASM PROGRESSION 38
9 COVID-19 30
10 POLYNEUROPATHY 29
11 DIARRHOEA 28
12 PYREXIA 28
13 PRODUCT USE ISSUE 27
14 CYTOPENIA 26
15 FATIGUE 25
16 ASTHENIA 24
17 ILL-DEFINED DISORDER 23
18 INFECTION 22
19 PNEUMONIA 22
20 NEOPLASM PROGRESSION 19
21 RASH 19
22 SEPSIS 18
23 PRODUCT DOSE OMISSION ISSUE 17
24 NAUSEA 16
25 CYTOKINE RELEASE SYNDROME 15
26 GENERAL PHYSICAL HEALTH DETERIORATION 15
27 HYPOTENSION 15
28 PANCYTOPENIA 15
29 INFUSION RELATED REACTION 14
30 NEUROPATHY PERIPHERAL 14
31 ACUTE KIDNEY INJURY 13
32 CARDIAC FAILURE 13
33 HEADACHE 13
34 INTENTIONAL PRODUCT USE ISSUE 13
35 OEDEMA PERIPHERAL 13
36 THROMBOCYTOPENIA 13
37 CYTOMEGALOVIRUS INFECTION 12
38 DYSPNOEA 12
39 HEPATITIS B 12
40 HEPATITIS C 12
41 PULMONARY EMBOLISM 12
42 CARDIOMYOPATHY 11
43 COUGH 11
44 LEUKOPENIA 11
45 CONSTIPATION 10
46 COVID-19 PNEUMONIA 10
47 DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT 10
48 HAEMATOTOXICITY 10
49 PLATELET COUNT DECREASED 10
50 VOMITING 10
51 ABDOMINAL PAIN 9
52 ANAEMIA 9
53 BACTERAEMIA 9
54 BLOOD CREATININE DECREASED 9
55 EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED 9
56 PLEURAL EFFUSION 9
57 PNEUMONITIS 9
58 RENAL FAILURE 9
59 TREATMENT FAILURE 9
60 TUMOUR FLARE 9
61 WEIGHT DECREASED 9
62 WHITE BLOOD CELL COUNT DECREASED 9
63 ARTHRALGIA 8
64 DIZZINESS 8
65 NEUTROPHIL COUNT DECREASED 8
66 PAIN IN EXTREMITY 8
67 THERAPY NON-RESPONDER 8
68 UROSEPSIS 8
69 ALANINE AMINOTRANSFERASE INCREASED 7
70 ASPARTATE AMINOTRANSFERASE INCREASED 7
71 BACK PAIN 7
72 BACTERIAL DISEASE CARRIER 7
73 C-REACTIVE PROTEIN DECREASED 7
74 CATHETER SITE THROMBOSIS 7
75 CONDITION AGGRAVATED 7
76 CONFUSIONAL STATE 7
77 CYTOMEGALOVIRUS INFECTION REACTIVATION 7
78 FEBRILE NEUTROPENIA 7
79 FOLLICULAR LYMPHOMA 7
80 GASTROENTERITIS 7
81 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 7
82 PRODUCT USE IN UNAPPROVED INDICATION 7
83 SYSTEMIC CANDIDA 7
84 THROMBOTIC MICROANGIOPATHY 7
85 ATRIAL FIBRILLATION 6
86 BRONCHOPULMONARY ASPERGILLOSIS 6
87 C-REACTIVE PROTEIN INCREASED 6
88 COR PULMONALE CHRONIC 6
89 DECREASED APPETITE 6
90 GASTRIC CANCER 6
91 HAEMORRHAGE 6
92 HYPERCALCAEMIA 6
93 LEFT VENTRICULAR FAILURE 6
94 METASTASES TO LUNG 6
95 MUSCLE SPASMS 6
96 BLASTOCYSTIS INFECTION 5
97 CARDIAC DISORDER 5
98 CARDIAC DYSFUNCTION 5
99 CEREBROVASCULAR ACCIDENT 5
100 DEEP VEIN THROMBOSIS 5
101 DIFFUSE LARGE B-CELL LYMPHOMA REFRACTORY 5
102 DISEASE RECURRENCE 5
103 DISTURBANCE IN ATTENTION 5
104 DRUG INTOLERANCE 5
105 ENTEROCOCCAL BACTERAEMIA 5
106 HAEMOGLOBIN DECREASED 5
107 HOSPITALISATION 5
108 HYPERTHERMIA 5
109 LONG QT SYNDROME 5
110 LYMPHADENOPATHY 5
111 METASTASES TO MENINGES 5
112 PRURITUS 5
113 PULMONARY FUNCTION TEST DECREASED 5
114 RENAL IMPAIRMENT 5
115 CARDIOTOXICITY 4
116 CHILLS 4
117 DEAFNESS 4
118 EPSTEIN-BARR VIRUS INFECTION 4
119 ILLNESS 4
120 LABORATORY TEST ABNORMAL 4
121 MALAISE 4
122 MUSCULOSKELETAL DISORDER 4
123 PAIN 4
124 PATHOLOGICAL FRACTURE 4
125 RED BLOOD CELL COUNT DECREASED 4
126 RHODOCOCCUS INFECTION 4
127 SOMNOLENCE 4
128 ARTHRITIS 3
129 BLOOD LACTATE DEHYDROGENASE DECREASED 3
130 BONE PAIN 3
131 CHEST PAIN 3
132 DEPRESSION 3
133 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 3
134 DYSPHAGIA 3
135 FALL 3
136 FEBRILE BONE MARROW APLASIA 3
137 GASTROINTESTINAL HAEMORRHAGE 3
138 HEPATIC LESION 3
139 HYPOGAMMAGLOBULINAEMIA 3
140 INSOMNIA 3
141 JOINT SWELLING 3
142 LYMPHOEDEMA 3
143 MEMORY IMPAIRMENT 3
144 MENTAL STATUS CHANGES 3
145 MUSCULAR WEAKNESS 3
146 NEOPLASM MALIGNANT 3
147 NO ADVERSE EVENT 3
148 NON-HODGKIN^S LYMPHOMA 3
149 PERFORMANCE STATUS DECREASED 3
150 PRODUCT ADMINISTRATION INTERRUPTED 3
151 RESPIRATORY TRACT INFECTION 3
152 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 3
153 URINARY TRACT INFECTION 3
154 ABDOMINAL PAIN UPPER 2
155 ABNORMAL BEHAVIOUR 2
156 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 2
157 ALOPECIA 2
158 ANAL INCONTINENCE 2
159 BACTERIAL INFECTION 2
160 BELL^S PALSY 2
161 BLISTER 2
162 BLOOD COUNT ABNORMAL 2
163 BLOOD CREATININE INCREASED 2
164 BLOOD GLUCOSE INCREASED 2
165 BLOOD PRESSURE INCREASED 2
166 BREAST CANCER 2
167 CANDIDA INFECTION 2
168 CARDIAC ARREST 2
169 CD19 ANTIGEN LOSS 2
170 CELLULITIS 2
171 DIFFUSE LARGE B-CELL LYMPHOMA STAGE IV 2
172 DISCOMFORT 2
173 DYSURIA 2
174 ENCEPHALOPATHY 2
175 ERYTHEMA 2
176 EXPIRED PRODUCT ADMINISTERED 2
177 EXTRAVASATION 2
178 FULL BLOOD COUNT DECREASED 2
179 GENERALISED TONIC-CLONIC SEIZURE 2
180 HIP FRACTURE 2
181 HYPERKALAEMIA 2
182 HYPOAESTHESIA 2
183 HYPOKALAEMIA 2
184 HYPONATRAEMIA 2
185 HYPOTHYROIDISM 2
186 HYPOXIA 2
187 INFESTATION 2
188 INFLUENZA 2
189 LIMB DISCOMFORT 2
190 LIVER ABSCESS 2
191 LIVER DISORDER 2
192 LIVER FUNCTION TEST INCREASED 2
193 LYMPHOPENIA 2
194 MYELODYSPLASTIC SYNDROME 2
195 MYELOSUPPRESSION 2
196 OROPHARYNGEAL PAIN 2
197 PERIPHERAL SWELLING 2
198 RASH PRURITIC 2
199 RESPIRATORY FAILURE 2
200 STOMATITIS 2
201 SWELLING 2
202 THERAPEUTIC RESPONSE CHANGED 2
203 THERAPY CHANGE 2
204 UPPER RESPIRATORY TRACT INFECTION 2
205 ABDOMINAL DISCOMFORT 1
206 ABDOMINAL LYMPHADENOPATHY 1
207 ABDOMINAL MASS 1
208 ABSCESS LIMB 1
209 ACUTE MYOCARDIAL INFARCTION 1
210 ACUTE RESPIRATORY DISTRESS SYNDROME 1
211 ACUTE RESPIRATORY FAILURE 1
212 ACUTE SINUSITIS 1
213 ADMINISTRATION SITE REACTION 1
214 ADRENAL INSUFFICIENCY 1
215 ADVERSE DRUG REACTION 1
216 AGRANULOCYTOSIS 1
217 AMNESIA 1
218 ANAL ULCER 1
219 ANGINA PECTORIS 1
220 ANOSMIA 1
221 AORTIC VALVE DISEASE 1
222 APPETITE DISORDER 1
223 ASCITES 1
224 ASPERGILLUS INFECTION 1
225 ASTHMA 1
226 ATAXIA 1
227 ATYPICAL PNEUMONIA 1
228 B-CELL SMALL LYMPHOCYTIC LYMPHOMA 1
229 BALANCE DISORDER 1
230 BLADDER DISCOMFORT 1
231 BLOOD CREATININE ABNORMAL 1
232 BLOOD FIBRINOGEN INCREASED 1
233 BLOOD GLUCOSE DECREASED 1
234 BLOOD MAGNESIUM DECREASED 1
235 BLOOD POTASSIUM ABNORMAL 1
236 BONE MARROW FAILURE 1
237 BRONCHITIS 1
238 CARDIAC FAILURE CONGESTIVE 1
239 CARDIO-RESPIRATORY ARREST 1
240 CARPAL TUNNEL SYNDROME 1
241 CD19 EXPRESSION DECREASED 1
242 CENTRAL NERVOUS SYSTEM LYMPHOMA 1
243 CHOLECYSTITIS 1
244 CHOLECYSTITIS INFECTIVE 1
245 CITROBACTER TEST POSITIVE 1
246 CLOSTRIDIUM DIFFICILE INFECTION 1
247 COMA HEPATIC 1
248 CONNECTIVE TISSUE DISORDER 1
249 CONTUSION 1
250 CREATININE RENAL CLEARANCE ABNORMAL 1
251 CSF LYMPHOCYTE COUNT ABNORMAL 1
252 DEHYDRATION 1
253 DEMENTIA 1
254 DEMENTIA ALZHEIMER^S TYPE 1
255 DEPRESSED LEVEL OF CONSCIOUSNESS 1
256 DEPRESSION SUICIDAL 1
257 DEVICE DIFFICULT TO USE 1
258 DIALYSIS DISEQUILIBRIUM SYNDROME 1
259 DISCONTINUED PRODUCT ADMINISTERED 1
260 DISORIENTATION 1
261 DRUG DOSE OMISSION BY DEVICE 1
262 DRUG EFFECT LESS THAN EXPECTED 1
263 DRUG ERUPTION 1
264 DRUG TOLERANCE 1
265 DRUG TOLERANCE DECREASED 1
266 DYSGEUSIA 1
267 DYSPHONIA 1
268 DYSSTASIA 1
269 EAR SWELLING 1
270 EATING DISORDER 1
271 ECZEMA 1
272 ELECTROCARDIOGRAM QT PROLONGED 1
273 EMBOLISM 1
274 ENTEROCOLITIS HAEMORRHAGIC 1
275 EOSINOPHIL COUNT DECREASED 1
276 EOSINOPHILIA 1
277 EPISTAXIS 1
278 ESCHERICHIA INFECTION 1
279 FACIAL PARALYSIS 1
280 FAILURE TO THRIVE 1
281 FEELING ABNORMAL 1
282 FIBRIN D DIMER INCREASED 1
283 FLUID RETENTION 1
284 FLUSHING 1
285 FULL BLOOD COUNT 1
286 FUNCTIONAL GASTROINTESTINAL DISORDER 1
287 GAIT INABILITY 1
288 GALLBLADDER OPERATION 1
289 GAMMA-GLUTAMYLTRANSFERASE INCREASED 1
290 GASTROINTESTINAL DISORDER 1
291 GENERALISED OEDEMA 1
292 GINGIVAL DISORDER 1
293 GLOMERULAR FILTRATION RATE DECREASED 1
294 GROIN PAIN 1
295 HAEMATOCRIT DECREASED 1
296 HAEMATOLOGICAL INFECTION 1
297 HAEMATOMA 1
298 HAEMOGLOBIN ABNORMAL 1
299 HAEMOGLOBIN INCREASED 1
300 HAEMOPTYSIS 1
301 HALLUCINATION 1
302 HEART RATE DECREASED 1
303 HEART RATE INCREASED 1
304 HEPATOSPLENOMEGALY 1
305 HICCUPS 1
306 HOT FLUSH 1
307 HUMERUS FRACTURE 1
308 HYPERCALCAEMIA OF MALIGNANCY 1
309 HYPERGLYCAEMIA 1
310 HYPERHIDROSIS 1
311 HYPERPHOSPHATAEMIA 1
312 HYPERTENSION 1
313 HYPERTHYROIDISM 1
314 HYPERURICAEMIA 1
315 HYPOACUSIS 1
316 HYPOMAGNESAEMIA 1
317 IMMUNISATION REACTION 1
318 IMMUNOSUPPRESSION 1
319 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1
320 INCARCERATED INGUINAL HERNIA 1
321 INCORRECT DISPOSAL OF PRODUCT 1
322 INFLAMMATORY MARKER INCREASED 1
323 INFUSION SITE REACTION 1
324 INJECTION SITE ERYTHEMA 1
325 INJECTION SITE HAEMORRHAGE 1
326 INSULIN-LIKE GROWTH FACTOR INCREASED 1
327 INSURANCE ISSUE 1
328 INTERNAL HAEMORRHAGE 1
329 INTESTINAL OBSTRUCTION 1
330 INTRACRANIAL MASS 1
331 KIDNEY INFECTION 1
332 LETHARGY 1
333 LOCALISED INFECTION 1
334 LOOSE TOOTH 1
335 LOWER RESPIRATORY TRACT INFECTION 1
336 LUNG DISORDER 1
337 LYMPHATIC DISORDER 1
338 LYMPHOCYTIC LYMPHOMA 1
339 LYMPHOMA TRANSFORMATION 1
340 MALIGNANT PLEURAL EFFUSION 1
341 MASS 1
342 MEAN ARTERIAL PRESSURE DECREASED 1
343 MEAN CELL HAEMOGLOBIN CONCENTRATION INCREASED 1
344 MEDICATION ERROR 1
345 MENTAL DISORDER 1
346 METABOLIC ACIDOSIS 1
347 METASTASES TO BONE 1
348 METASTASES TO KIDNEY 1
349 METASTASES TO LYMPH NODES 1
350 METASTASIS 1
351 MIGRAINE 1
352 MUCOSAL INFLAMMATION 1
353 MUSCULOSKELETAL DISCOMFORT 1
354 MYALGIA 1
355 MYOCARDIAL INFARCTION 1
356 MYOCARDITIS 1
357 NASAL CONGESTION 1
358 NASAL OBSTRUCTION 1
359 NASOPHARYNGITIS 1
360 NECK MASS 1
361 NEOPLASM RECURRENCE 1
362 NERVOUS SYSTEM DISORDER 1
363 NEUTROPENIC INFECTION 1
364 NIGHT SWEATS 1
365 NON-HODGKIN^S LYMPHOMA RECURRENT 1
366 NOROVIRUS INFECTION 1
367 OBSTRUCTION GASTRIC 1
368 OROPHARYNGEAL DISCOMFORT 1
369 OTORRHOEA 1
370 OXYGEN SATURATION DECREASED 1
371 PANIC ATTACK 1
372 PARAINFLUENZAE VIRUS INFECTION 1
373 PELVIC MASS 1
374 PERIPHERAL ARTERY OCCLUSION 1
375 PERIPHERAL SENSORY NEUROPATHY 1
376 PNEUMOCYSTIS JIROVECII PNEUMONIA 1
377 PNEUMONIA ADENOVIRAL 1
378 PNEUMONIA ASPIRATION 1
379 PNEUMONIA FUNGAL 1
380 PNEUMONIA RESPIRATORY SYNCYTIAL VIRAL 1
381 POLLAKIURIA 1
382 PRE-EXISTING CONDITION IMPROVED 1
383 PRESCRIBED OVERDOSE 1
384 PRODUCT AVAILABILITY ISSUE 1
385 PRODUCT COMMUNICATION ISSUE 1
386 PRODUCT DOSE OMISSION IN ERROR 1
387 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 1
388 PRODUCT PREPARATION ERROR 1
389 PRODUCT PREPARATION ISSUE 1
390 PRODUCT PRESCRIBING ISSUE 1
391 PRODUCT STORAGE ERROR 1
392 PRODUCT SUPPLY ISSUE 1
393 PRODUCTIVE COUGH 1
394 PSEUDOMONAL SEPSIS 1
395 PSORIASIS 1
396 PULMONARY SEPSIS 1
397 PYOMYOSITIS 1
398 RALES 1
399 RECURRENT CANCER 1
400 RED CELL DISTRIBUTION WIDTH INCREASED 1
401 RENAL INJURY 1
402 RESPIRATORY DISORDER 1
403 RESPIRATORY SYNCYTIAL VIRUS INFECTION 1
404 RETROPERITONEAL ABSCESS 1
405 SECOND PRIMARY MALIGNANCY 1
406 SEPTIC SHOCK 1
407 SINUSITIS 1
408 SKIN DISCOLOURATION 1
409 SKIN DISORDER 1
410 SLEEP DISORDER 1
411 SMALL INTESTINAL PERFORATION 1
412 SPINAL CORD COMPRESSION 1
413 SPLENIC RUPTURE 1
414 SUSPECTED COVID-19 1
415 TACHYCARDIA 1
416 TENDON RUPTURE 1
417 THERAPEUTIC PRODUCT EFFECT DECREASED 1
418 THERAPEUTIC RESPONSE DECREASED 1
419 THERAPY CESSATION 1
420 THERAPY INTERRUPTED 1
421 THROMBOSIS 1
422 TONGUE BLISTERING 1
423 TONGUE EXFOLIATION 1
424 TONGUE HAEMORRHAGE 1
425 TOOTH DISORDER 1
426 TOOTH INFECTION 1
427 TOXIC CARDIOMYOPATHY 1
428 TOXIC SKIN ERUPTION 1
429 TOXICITY TO VARIOUS AGENTS 1
430 TRANSPLANT ASSOCIATED THROMBOTIC MICROANGIOPATHY 1
431 TREMOR 1
432 TUMOUR LYSIS SYNDROME 1
433 TUMOUR PSEUDOPROGRESSION 1
434 URINARY INCONTINENCE 1
435 VISION BLURRED 1
436 VISUAL IMPAIRMENT 1
437 WEIGHT ABNORMAL 1
438 WEIGHT INCREASED 1
439 WHITE BLOOD CELL COUNT ABNORMAL 1
440 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1